JIA Mu, GAN Xiaolu. Effect of flupentixol and melitracen tablets combinedwith Shugan Jieyu Capsule in the treatment of refractory gastroesophageal reflux[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 21-24,28. DOI: 10.7619/jcmp.201914005
Citation: JIA Mu, GAN Xiaolu. Effect of flupentixol and melitracen tablets combinedwith Shugan Jieyu Capsule in the treatment of refractory gastroesophageal reflux[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 21-24,28. DOI: 10.7619/jcmp.201914005

Effect of flupentixol and melitracen tablets combinedwith Shugan Jieyu Capsule in the treatment of refractory gastroesophageal reflux

More Information
  • Received Date: May 04, 2019
  • Accepted Date: June 14, 2019
  • Available Online: February 23, 2021
  • Published Date: July 27, 2019
  •   Objective  To investigate the clinical effect of Flupentixol and Melitracen Tablets combined with Shugan Jieyu Capsule in the treatment of refractory gastroesophageal reflux disease (GERD).
      Methods  A total of 90 patients with refractory GERD admitted to Department of Digestion were divided into control group and study group according to random number table method, with 45 cases in each group. The control group was treated with optimized treatment by proton pump inhibitors (PPIs), the study group was treated with Flupentixol and Melitracen Tablets combined with Shugan Jieyu Capsule on the basis of the control group, the treatments of both groups lasted for 12 weeks and the patients were followed up closely. The scores of GERD symptoms, Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA) before treatment, and at 6 and 12 weeks after treatment were compared. The clinical efficacy and safety of the two groups were evaluated.
      Results  There was no dropout case in the control group and 1 case removed from the study group. The Reflux Disease Questionnaire (RDQ), HAMD and HAMA scores of the two groups showed a gradual downward trend. The RDQ, HAMD and HAMA scores at 6 and 12 weeks after treatment were significantly lower than before treatment (P < 0.05), and the study group was significantly lower than that in the control group(P < 0.05). The total effective rate of the study group was significantly higher than that of the control group (95.45% vs. 80.00%, P < 0.05). There were only a few mild discomfort symptoms in the two groups during the treatment period, which did not affect the continuous treatment.
      Conclusion  Flupentixol and Melitracen Tablets combined with Shugan Jieyu Capsule on the basis of routine optimized treatment by PPIs can effectively relieve the clinical symptoms of refractory GERD and improve the mental state, which is a reliable therapy with remarkable curative effect and high safety.
  • [1]
    李玉芳, 乔大伟, 肖云, 等. 胃食管反流病患者食管动力学特点及其诊治[J]. 实用医学杂志, 2018, 34(3): 490-492. doi: 10.3969/j.issn.1006-5725.2018.03.037
    [2]
    李意茹, 李亚, 牛春燕. 质子泵抑制剂在胃食管反流病中应用的研究进展[J]. 国际消化病杂志, 2018, 38(3): 170-173. doi: 10.3969/j.issn.1673-534X.2018.03.005
    [3]
    张伟, 仇明. 质子泵抑制剂与难治性胃食管反流病[J]. 中华胃食管反流病电子杂志, 2017, 4(3): 7-9. https://www.cnki.com.cn/Article/CJFDTOTAL-SDFL201703001.htm
    [4]
    Kwong Ming, Fock K M, Talley N J, 等. 亚太地区胃食管反流病的处理共识: 更新版[J]. 胃肠病学, 2008, 13(7): 421-436. doi: 10.3969/j.issn.1008-7125.2008.07.010
    [5]
    陈旻湖, 侯晓华, 肖英莲, 等. 2014年中国胃食管反流病专家共识意见[J]. 胃肠病学, 2015(3): 155-168. doi: 10.3969/j.issn.1008-7125.2015.03.007
    [6]
    王天佑, 郭子皓, 陈婧, 等. 胃食管反流病患者中胃食管连接部形态与24 h食管pH-阻抗监测及胃镜结果的相关性研究[J]. 胃肠病学和肝病学杂志, 2017, 26(8): 898-901. doi: 10.3969/j.issn.1006-5709.2017.08.015
    [7]
    肖茹萍, 陈阳, 卜平. 难治性胃食管反流病与CYP2C19基因多态性的相关性研究[J]. 医学研究杂志, 2017, 46(11): 58-61. doi: 10.11969/j.issn.1673-548X.2017.11.015
    [8]
    陆清, 雷甜甜, 王一岚, 等. 难治性胃食管反流疾病的发病机制和治疗进展[J]. 四川医学, 2017, 38(10): 1212-1216. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX201710032.htm
    [9]
    耿华, 申青霞, 任顺平. 从郁论治难治性胃食管反流病[J]. 中医药学报, 2018, 46(5): 82-84. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB201805018.htm
    [10]
    陈晓仰. 汕头市功能性消化不良儿童情志、体格、家庭情况调查及发病危险因素与预防措施分析[J]. 中国妇幼保健, 2017, 32(17): 4242-4246. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201717075.htm
    [11]
    安万杰, 苏高建, 胡静. 枸橼酸莫沙必利分散片联合氟哌噻吨美利曲辛片治疗功能性消化不良的临床疗效观察[J]. 实用临床医药杂志, 2017, 21(21): 189-190. doi: 10.7619/jcmp.201721076
    [12]
    徐淑宁, 乔磊, 刘莺. 氟哌噻吨美利曲辛片联合解郁丸治疗肿瘤患者抑郁症的疗效观察[J]. 中国临床医生杂志, 2017, 45(9): 65-67. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS201709025.htm
    [13]
    李克建, 陈云, 郭娟, 等. 疏肝解郁胶囊联合草酸艾司西酞普兰治疗脑卒中患者焦虑抑郁状态的疗效观察[J]. 国际精神病学杂志, 2017, 44(2): 260-262. https://www.cnki.com.cn/Article/CJFDTOTAL-GWYJ201702019.htm
    [14]
    王奇, 戴小华. 舒肝解郁胶囊治疗冠心病PCI术后焦虑抑郁症研究进展[J]. 中西医结合心脑血管病杂志, 2017, 15(7): 820-822. doi: 10.3969/j.issn.1672-1349.2017.07.015
    [15]
    杨小艳, 郭传勇, 张旭, 等. 氟哌噻吨美利曲辛联合舒肝解郁胶囊治疗难治性胃食管反流病的疗效分析[J]. 中华医学杂志, 2017, 97(44): 3475-3479. doi: 10.3760/cma.j.issn.0376-2491.2017.44.008
  • Related Articles

    [1]ZHANG Wenhua, LI Li, ZHU Liqun, ZHOU Yingfeng, BU Hongbing, SUN Guofu, ZHANG Wei, RUAN Yuan. Construction of early fluid resuscitation management evaluation system for acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2023, 27(14): 104-108, 114. DOI: 10.7619/jcmp.20231216
    [2]LI Xiang, XUE Chao, ZHANG Liyun, JIANG Liqing, ZHU Hanzhao, ZHAI Meng′en, LIANG Hongliang, YU Shiqiang, LIU Jincheng, DUAN Weixun. Construction of clinical pathway evaluation system for minimally invasive treatment of congenital heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 56-60, 65. DOI: 10.7619/jcmp.20221288
    [3]ZHENG Tao, NING Songyi, ZHU Ying. Construction of nursing quality evaluation system for diabetic retinopathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 116-119, 123. DOI: 10.7619/jcmp.20213425
    [4]YANG Hongfeng, ZHOU Xiaojiang. Effects of enhanced recovery after surgery concept combined with clinical nursing pathway model on related rehabilitation indexes and mental state of patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(22): 78-81. DOI: 10.7619/jcmp.20213743
    [5]WANG Hui. Effect of emergency nursing pathway on curative efficacy of acute coronary syndrome patients[J]. Journal of Clinical Medicine in Practice, 2017, (8): 11-13. DOI: 10.7619/jcmp.201708004
    [6]ZHAO Hui, YANG Guofeng, YI Tianshuang. Evaluation of clinical nursing pathway in the treatment of rheumatoid arthritis and rehabilitation nursing[J]. Journal of Clinical Medicine in Practice, 2017, (6): 74-77. DOI: 10.7619/jcmp.201706023
    [7]ZHOU Erxia, LI Rongxia. Effect of emergency nursing pathway in treating patients with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2016, (6): 1-3. DOI: 10.7619/jcmp.201606001
    [8]CHEN Maochun. Research on construction of evaluation indicators system of nursing safety management in operating room[J]. Journal of Clinical Medicine in Practice, 2015, (12): 91-93,100. DOI: 10.7619/jcmp.201512029
    [9]BIAN Qiugui, XU Yinghong, DING Xiafen, DING Jing, WEI Li. Application the nursing pathway in patients treated with digestive endoscopy[J]. Journal of Clinical Medicine in Practice, 2015, (2): 36-39. DOI: 10.7619/jcmp.201502012
    [10]YUAN Hai-juan. Evaluation of clinical nursing pathway in perioperative health education for patients with breast cancer[J]. Journal of Clinical Medicine in Practice, 2012, (6): 4-5,8. DOI: 10.3969/j.issn.1672-2353.2012.06.002
  • Cited by

    Periodical cited type(2)

    1. 张晓霞,冯玲. 5例HIV合并急性阑尾炎患者腹腔镜手术护理分析. 中国继续医学教育. 2020(05): 179-181 .
    2. 黄锐敏,杨艳艳. 心理护理干预应用于监管场所艾滋病患者中的实施意义. 吉林医学. 2020(11): 2786-2787 .

    Other cited types(0)

Catalog

    Article views (439) PDF downloads (5) Cited by(2)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return